Corrigendum: Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro (Cell Discovery (2017) 3 (17006) DOI: 10.1038/celldisc.2017.6);Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro

Cell Discovery

Volumn 3, Issue , 2017, Pages

  Wu, Yaoxing ^a   Liu, Qingxiang ^a   Zhou, Jie ^a   Xie, Weihong ^a   Chen, Cheng ^b   Wang, Zefang ^b   Yang, Haitao ^b,c   Cui, Jun ^a,d  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TIANJIN UNIVERSITY   (China)

^c Tianjin International Joint Academy of Biotechnology and Medicine   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BINDING PROTEIN; JANUS KINASE; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2 B3; NONSTRUCTURAL PROTEIN 4B; STAT PROTEIN; TANK BINDING KINASE 1; UNCLASSIFIED DRUG; VIRAL PROTEIN;

A-549 CELL LINE; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CYTOKINE PRODUCTION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS REPLICATION; ZIKA VIRUS;

EID: 85021049648     PISSN: None     EISSN: 20565968     Source Type: Journal    
DOI: 10.1038/celldisc.2017.14     Document Type: Erratum

References (42)

1. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952; 46: 509-520.
2. Rossi SL, Tesh RB, Azar SR et al. Characterization of a novel murine model to study Zika virus. Am J Trop Med Hyg 2016; 94: 1362-1369.
3. Ioos S, Mallet HP, Leparc Goffart I, Gauthier V, Cardoso T, Herida M. Current Zika virus epidemiology and recent epidemics. Med Mal Infect 2014; 44:302-307.
4. Petersen E, Wilson ME, Touch S et al. Rapid spread of Zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016. Brazil Olympic Games. Int J Infect Dis 2016; 44: 11-15.
5. Cao-Lormeau VM, Roche C, Teissier A et al. Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis 2014; 20: 1085-1086.
6. Calvet G, Aguiar RS, Melo AS et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016; 16: 653-660.
7. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and birth defects-reviewing the evidence for causality. N Engl J Med 2016; 374: 1981-1987.
8. Tang H, Hammack C, Ogden SC et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 2016; 18: 587-590.
9. Martines RB, Bhatnagar J, Keating MK et al. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses-Brazil, 2015. MMWR 2016; 65: 159-160.
10. Govero J, Esakky P, Scheaffer SM et al. Zika virus infection damages the testes in mice. Nature 2016; 540: 438-442.
11. Schneider WM, Chevillotte MD, Rice CM. Interferonstimulated genes: a complex web of host defenses. Annu Rev Immunol 2014; 32: 513-545.
12. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
13. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity 2011; 34: 680-692.
14. Suthar MS, Aguirre S, Fernandez-Sesma A. Innate immune sensing of flaviviruses. PLoS Pathog 2013; 9: e1003541.
15. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122: 669-682.
16. Liu S, Cai X, Wu J et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 2015; 347: aaa2630.
17. Savidis G, Perreira JM, Portmann JM et al. The IFITMs inhibit Zika virus replication. Cell Rep 2016; 15:
18. Beachboard DC, Horner SM. Innate immune evasion strategies of DNA and RNA viruses. Curr Opin Microbiol 2016; 32: 113-119.
19. Zmurko J, Neyts J, Dallmeier K. Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Rev Med Virol 2015; 25: 205-223.
20. Nazmi A, Dutta K, Hazra B, Basu A. Role of pattern recognition receptors in flavivirus infections. Virus Res 2014;185: 32-40
21. Kumar A, Hou S, Airo AM et al. Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep 2016; 17: 1766-1775.
22. Grant A, Ponia SS, Tripathi S et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 2016; 19: 882-890.
23. Hamel R, Dejarnac O, Wichit S et al. Biology of Zika virus infection in human skin cells. J Virol 2015; 89: 8880-8896.
24. Castillo Ramirez JA, Urcuqui-Inchima S. Dengue virus control of type I IFN responses: a history of manipulation and control. J Interferon Cytokine Res 2015; 35: 421-430.
25. Laurent-Rolle M, Morrison J, Rajsbaum R et al. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe 2014; 16: 314-327.
26. Morrison J, Laurent-Rolle M, Maestre AM et al. Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog 2013; 9: e1003265.
27. Upton JW, Chan FK. Staying alive: cell death in antiviral immunity. Mol Cell 2014; 54: 273-280.
28. Chattopadhyay S, Kuzmanovic T, Zhang Y, Wetzel JL, Sen GC. Ubiquitination of the transcription factor IRF-3 activates RIPA, the apoptotic pathway that protects mice from viral pathogenesis. Immunity 2016; 44: 1151-1161.
29. Boyle KB, Randow F. The role of 'eat-me' signals and autophagy cargo receptors in innate immunity. Curr Opin Microbiol 2013; 16: 339-348.
30. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009; 34: 259-269
31. Diamond MS. Mechanisms of evasion of the type I interferon antiviral response by flaviviruses. J Interferon Cytokine Res 2009; 29: 521-530.
32. Carthagena L, Bergamaschi A, Luna JM et al. Human TRIM gene expression in response to interferons. PLoS ONE 2009; 4: e4894.
33. Versteeg GA, Rajsbaum R, Sanchez-Aparicio MT et al. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 2013; 38: 384-398.
34. Pertel T, Hausmann S, Morger D et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011 472: 361-365.
35. Arimoto K, Funami K, Saeki Y et al. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci USA 2010; 107: 15856-15861.
36. Liu B, Zhang M, Chu H et al. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat Immunol 2016; 18: 214-224.
37. Gack MU, Shin YC, Joo CH et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446: 916-920.
38. Cugola FR, Fernandes IR, Russo FB et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 2016; 534: 267-271.
39. Li C, Xu D, Ye Q et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 2016; 19: 672.
40. Gack MU, Diamond MS. Innate immune escape by Dengue and West Nile viruses. Curr Opin Virol 2016; 20: 119-128.
41. Xing J, Weng L, Yuan B et al. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nat Immunol 2016; 17: 1373-1380.
42. Cui J, Song Y, Li Y et al. USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptors. Cell Res2014; 24: 400-416.